FDA Initiates Nationwide Recall of Alyacen Birth Control Due to Impurity Concerns

The FDA has announced a nationwide recall of several lots of Alyacen 7/7/7 birth control tablets. The recall was prompted by tests revealing unacceptable impurity and degradation product levels, failing quality standards. This Class II recall suggests a potential for temporary or reversible health issues.